Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Oncology Institute (TOI) Tax Provisions (2020 - 2025)

Oncology Institute's Tax Provisions history spans 5 years, with the latest figure at -$131000.0 for Q2 2025.

  • For Q2 2025, Tax Provisions changed N/A year-over-year to -$131000.0; the TTM value through Dec 2025 reached -$131000.0, changed N/A, while the annual FY2025 figure was -$131000.0, N/A changed from the prior year.
  • Tax Provisions reached -$131000.0 in Q2 2025 per TOI's latest filing, up from -$314000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $799000.0 in Q3 2021 to a low of -$2.5 million in Q4 2021.
  • Average Tax Provisions over 4 years is -$83153.8, with a median of $44000.0 recorded in 2023.
  • The largest YoY upside for Tax Provisions was 6254.89% in 2021 against a maximum downside of 388.16% in 2021.
  • A 4-year view of Tax Provisions shows it stood at -$2.5 million in 2021, then soared by 85.13% to -$367000.0 in 2022, then grew by 14.44% to -$314000.0 in 2023, then skyrocketed by 58.28% to -$131000.0 in 2025.
  • Per Business Quant, the three most recent readings for TOI's Tax Provisions are -$131000.0 (Q2 2025), -$314000.0 (Q4 2023), and $135000.0 (Q3 2023).